1-8359846-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001042681.2(RERE):c.3536G>A(p.Arg1179Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000341 in 1,610,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1179L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001042681.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RERE | NM_001042681.2 | c.3536G>A | p.Arg1179Gln | missense_variant | Exon 19 of 23 | ENST00000400908.7 | NP_001036146.1 | |
RERE | NM_012102.4 | c.3536G>A | p.Arg1179Gln | missense_variant | Exon 20 of 24 | NP_036234.3 | ||
RERE | NM_001042682.2 | c.1874G>A | p.Arg625Gln | missense_variant | Exon 9 of 13 | NP_001036147.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152116Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248700Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134920
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1458622Hom.: 0 Cov.: 33 AF XY: 0.0000303 AC XY: 22AN XY: 725798
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152234Hom.: 0 Cov.: 30 AF XY: 0.0000403 AC XY: 3AN XY: 74434
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.3536G>A (p.R1179Q) alteration is located in exon 20 (coding exon 18) of the RERE gene. This alteration results from a G to A substitution at nucleotide position 3536, causing the arginine (R) at amino acid position 1179 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1179 of the RERE protein (p.Arg1179Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with RERE-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RERE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at